Literature DB >> 12939926

The BEST study--a prospective study to compare business class versus economy class air travel as a cause of thrombosis.

Barry F Jacobson1, Marion Münster, Alberto Smith, Kevin G Burnand, Andrew Carter, A Talib O Abdool-Carrim, Elizabeth Marcos, Piet J Becker, Timothy Rogers, Dirk le Roux, Jennifer L Calvert-Evers, Marietha J Nel, Robyn Brackin, Martin Veller.   

Abstract

BACKGROUND: As many as 10% of airline passengers travelling without prophylaxis for long distances may develop a venous thrombosis. There is, however, no evidence that economy class travellers are at increased risk of thrombosis.
OBJECTIVES: A suitably powered prospective study, based on the incidence of deep-vein thrombosis (DVT) reported in previous studies on long-haul flights, was designed to determine the incidence of positive venous duplex scans and D-dimer elevations in low and intermediate-risk passengers, comparing passengers travelling in business and economy class. PATIENTS/
METHODS: Eight hundred and ninety-nine passengers were recruited (180 travelling business class and 719 travelling economy). D-dimers were measured before and after the flight. A value greater than 500 ng/ml was accepted as abnormal. A thrombophilia screen was conducted which included the factor V Leiden mutation, the prothombin 20210A mutation, protein C and S levels, antithrombin levels, and anticardiolipin antibodies immunoglobulin G (IgG) and immunoglobulin M (IgM). On arrival, lower limb compression ultrasonography of the deep veins was performed. Logistical regression analysis was used to determine the risk factors related to abnormally high D-dimer levels.
RESULTS: Only 434 subjects had a full venous duplex scan performed. None had ultrasonic evidence of venous thrombosis. Nine passengers tested at departure had elevated D-dimer levels and these volunteers were excluded from further study. Seventy-four of the 899 passengers had raised D-dimers on arrival. Twenty-two of 180 business class passengers (12%) developed elevated D-dimers compared with 52 of 719 economy class passengers (7%). There was no significant association between elevation of D-dimers and the class flown (odds ratio (OR) 0.61, p = 0.109). The factor V Leiden mutation, factor VIII levels and the use of aspirin were, however, associated with raised D-dimers (OR 3.36, p = 0.024; OR 1.01, p = 0.014; and OR 2.04, p = 0.038, respectively). Five hundred and five passengers were contacted within 6 months and none reported any symptoms of a clinical thrombosis or pulmonary embolus.
CONCLUSION: The incidence of ultrasonically proven DVT is much lower than previously reported. However, more than 10% of all passengers developed raised D-dimers, which were unrelated to the class flown. A rise in D-dimers is associated with an inherent risk of thrombosis and/or thrombophilia, demonstrates activation of both the coagulation and fibrinolytic systems during long-haul flights, and may indicate the development of small thrombi.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939926

Source DB:  PubMed          Journal:  S Afr Med J


  5 in total

Review 1.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

2.  Jobs encompassing prolonged sitting in cramped positions and risk of venous thromboembolism: cohort study.

Authors:  Poul Suadicani; Harald Hannerz; Elsa Bach; Finn Gyntelberg
Journal:  JRSM Short Rep       Date:  2012-02-14

Review 3.  Air travel and venous thromboembolism: a systematic review.

Authors:  John T Philbrick; Rebecca Shumate; Mir S Siadaty; Daniel M Becker
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128

4.  Direct Oral Anticoagulants and Travel-related Venous Thromboembolism.

Authors:  Supat Chamnanchanunt; Ponlapat Rojnuckarin
Journal:  Open Med (Wars)       Date:  2018-11-27

5.  COVID-19, long flights, and deep vein thrombosis: What we know so far.

Authors:  Zbigniew Krasiński; Andre Chou; Hubert Stępak
Journal:  Cardiol J       Date:  2021-08-06       Impact factor: 2.737

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.